EUVIMEDEUVIMED entdecken
Crossref

Modern CINV prevention: fewer medications, greater comfort for the patient and the therapeutic team

Łukasz Hajac, Martyna Hajac, Piotr Hudziec

OncoReview · 30.09.2025 · 15 (2(58)) · 41-45

DOI: 10.24292/01.or.152991025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, online erschienen am 30.09.2025. Verfasst von Łukasz Hajac und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nausea and vomiting are among the most frequently reported adverse effects of systemic oncological treatment. Effective prevention is key to improving patients’ quality of life. Nausea and vomiting can be early, late, or preemptive. Both the mechanism of their onset and the therapeutic methods vary. Treatment primarily involves 5-HT3 antagonists, glucocorticosteroids, NK1 antagonists, and olanzapine. Modern antiemetic therapy is safe and effective in most cases. The most common side effects include headache, constipation, and sedation.

Zitieren

APA

Hajac, Ł., Hajac, M., & Hudziec, P. (2025). Modern CINV prevention: fewer medications, greater comfort for the patient and the therapeutic team. OncoReview, 15(2(58)), 41-45. https://doi.org/10.24292/01.or.152991025

Vancouver

Hajac Ł, Hajac M, Hudziec P. Modern CINV prevention: fewer medications, greater comfort for the patient and the therapeutic team. OncoReview. 2025;15(2(58)):41-45. doi:10.24292/01.or.152991025

BibTeX
@article{Hajac2025,
  author = {Hajac, Łukasz and Hajac, Martyna and Hudziec, Piotr},
  title = {Modern CINV prevention: fewer medications, greater comfort for the patient and the therapeutic team},
  journal = {OncoReview},
  year = {2025},
  volume = {15},
  number = {2(58)},
  pages = {41--45},
  doi = {10.24292/01.or.152991025}
}
Kostenlos starten →